Wird geladen...
SGLT-2 Inhibitors in Development for Type 2 Diabetes Treatment
The prevalence of type 2 diabetes is increasing worldwide. The majority of currently available glucose-lowering agents work via insulin-dependent mechanisms and have significant limitations. Hence, there is a need for newer treatments utilizing novel therapeutic targets. Drugs which inhibit the sodi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SBDR - Society for Biomedical Diabetes Research
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3280669/ https://ncbi.nlm.nih.gov/pubmed/22262072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2011.8.348 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|